Companies: 10,795·Total market cap: $144.5T
Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

REGNNASDAQHealthcare● Active
$611.34
$-24.11(-3.79%)
Market Cap$63.0B
P/E Ratio
52W High$821.11
52W Low$503.25
Overview

Regeneron Pharmaceuticals, Inc.(REGN)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · REGN · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$8.61B$9.01B$10.84B$7.74B$5.69B
Net Receivables$5.74B$6.21B$5.67B$5.33B$6.04B
Inventory$3.20B$3.09B$2.58B$2.40B$1.95B
Total Current Assets$18.02B$18.66B$19.48B$15.88B$14.01B
PP&E Net$5.12B$4.60B$4.15B$3.76B$3.48B
Goodwill$0.00B$0.00B$0.00B$0.00B$0.00B
Intangible Assets$1.26B$1.15B$1.04B$0.92B$0.01B
Total Assets$40.56B$37.76B$33.08B$29.21B$25.43B
Liabilities
Short-Term Debt$0.00B$0.00B$0.00B$0.00B$0.00B
Accounts Payable$0.94B$0.79B$0.61B$0.59B$0.56B
Total Current Liabilities$4.37B$3.94B$3.42B$3.14B$3.93B
Long-Term Debt$1.99B$1.98B$1.98B$1.98B$1.98B
Total Liabilities$9.30B$8.41B$7.11B$6.55B$6.67B
Stockholders Equity
Retained Earnings$35.80B$31.67B$27.26B$23.31B$18.97B
Total Stockholders Equity$31.26B$29.35B$25.97B$22.66B$18.77B
Total Liab & Equity(computed)$40.56B$37.76B$33.08B$29.21B$25.43B
Debt Summary
Total Debt$2.71B$2.70B$2.70B$2.70B$2.70B
Net Debt($0.41B)$0.22B($0.03B)($0.40B)($0.19B)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B

深入了解Regeneron Pharmaceuticals, Inc.

关于Regeneron Pharmaceuticals, Inc.(REGN)资产负债表

Regeneron Pharmaceuticals, Inc.总资产$40.56B,现金及短期投资$8.61B,总负债$9.30B,总债务$2.71B,股东权益$31.26B。

常见问题

REGN · 4 问

Regeneron Pharmaceuticals, Inc.总债务$2.71B,净债务($0.41B)。

REGN total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10